PRS6 A CANADIAN COST ANALYSIS OF 4 RANDOMIZED DOUBLEBLIND ACTIVE COMPARATOR TRIALS WITH TELITHROMYCIN IN ACUTE EXACERBATION OF CHRONIC BRONCHITIS (AECB) AND COMMUNITY-ACQUIRED PNEUMONIA (CAP)

Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)65930-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65930-X/fulltext
Section Title :
Section Order : 297
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65930-X&doi=10.1016/S1098-3015(10)65930-X
HEOR Topics :
Tags :
Regions :